HD Biosciences Co., Ltd. a WuXi AppTec company, is a biology-focused preclinical drug discovery platform based in Shanghai China, with operation facilities in San Diego, California and Cranbury, New Jersey, USA. The company offers comprehensive services around target validation, plate-based pharmacology, hit identification and lead discovery, therapeutic antibody discovery, PK/PD and bioanalysis, in vivo pharmacology, as well as other research and development services. The company currently collaborates with global pharmaceutical and biotechnology companies, and has established strategic partnership with many key R&D advancements in clients’ portfolio. The company’s strong scientific expertise, high-quality and consistent deliveries, which constantly meet or exceed the client expectations, have fortified its global leadership as a comprehensive and reliable preclinical drug discovery platform.